NCT01055353已完成不适用
Evaluation of Target Organs Damage in Hypertensive Patients Followed in General Practice With no Known Cardiovascular (CV) or Renal Disease, Stratified According to Blood Pressure Control
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,857
- 试验地点
- 1
- 主要终点
- To evaluate the frequency of evaluation of preclinical target organs damage in hypertensive patients with no known cardiovascular or renal disease, by taking blood pressure (controlled or uncontrolled HT*) into account
研究概览
简要总结
Evaluation of target organs damage in hypertensive patients with no known cardiovascular (CV) or renal disease, stratified according to level of blood pressure control
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •diagnosis of essential hypertension (treated or untreated); HT not discovered on the day of the consultation; no documented clinical cardiovascular or renal disease.
排除标准
- 未提供
结局指标
主要结局
To evaluate the frequency of evaluation of preclinical target organs damage in hypertensive patients with no known cardiovascular or renal disease, by taking blood pressure (controlled or uncontrolled HT*) into account
时间窗: once / 1 Year
次要结局
- To describe the patient profile (socio-demographic, risk factors, comorbidities, global CV risk level estimated by the doctor and calculated retrospectively [according to ESH 2007]) associated with screening for target organs damage
- To describe the modalities of patient follow-up and management
- To compare the frequency of evaluation of target organs damage as a function of the modalities of management of CV risk factors at the time of the consultation.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Evaluation of Target Organs Impairment on Patients Suffering From High Blood PressureBlood PressureNCT00925470AstraZeneca1,200
Unknown
不适用
Central Hemodynamic and Sodium UrinaryHypertensionNCT03932422Hospital de Base100
已完成
不适用
Target Organ Damage and Polymorphisms Vav-2 and Vav-3 in Hypertensive SubjectsHypertensionNCT02022618Fundacion para la Investigacion y Formacion en Ciencias de la Salud454
尚未招募
不适用
Early Target Organ Damage in patients with Hypertension: a Magnetic Resonance Imaging (MRI) Approachhigh blood pressure100192801000796310057166HypertensionNL-OMON31305eids Universitair Medisch Centrum160
已完成
不适用
To view the influence of gum diseases on heart activity/function among blood pressure patientsCTRI/2018/08/015383Dr Nirosha Narendran150
